Nicotine patch does not increase risk of adverse events among CHD patients -- study.
This article was originally published in The Tan Sheet
Executive Summary
NICOTINE PATCH THERAPY DOES NOT INCREASE CARDIAC EVENTS incidence in patients with cardiac disease, according to a study conducted by Anne Joseph, MD, University of Minnesota, et al., published in the Dec. 12 issue of The New England Journal of Medicine. The authors determined that "serious adverse events are common and occur at nearly the same rate among subjects with cardiovascular disease who try to quit smoking, regardless of whether they use transdermal nicotine or placebo."
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning